Health & Nutrition

Themenbereich / / Health & Nutrition

Sortiere PresseMitteilungen nach: Titel (A\D) Datum (A\D)

Seiten sind aktuell sortiert nach: Datum (erst neue PresseMitteilungen)

Algae Dynamics Corp Enters Into a Letter of Intent With Bonify to Produce Unique Cannabis Oil Products; Accelerates Go-to-Market Strategy

TORONTO, ON -- (Marketwired) -- 08/16/17 -- ALGAE DYNAMICS CORP (OTCQB: ADYNF) (the "Company"), a company focused on the development of unique health products and pharmaceuticals utilizing cannabis and algae oils, today announced that it has further refined its relationship with 6779264 Manitoba Ltd dba Bonify ("Bonify") in a Letter of Intent ("LOI") dated August 10, 2017. Bonify is a Licensed Producer, pursuant to the Access to Cannabis for Medical Purposes Regulations in Canada, with the capability to grow multiple strains of cannabis in its state-of-the-art 32 ...


IntelGenx Reports Second Quarter 2017 Financial Results

SAINT LAURENT, QUEBEC -- (Marketwired) -- 08/10/17 -- IntelGenx Technologies Corp. (TSX VENTURE: IGX)(OTCQX: IGXT) (the "Company" or "IntelGenx") today reported financial results for the second quarter ended June 30, 2017. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles except where noted otherwise.2017 Second Quarter Financial Highlights:Recent Developments:"We continued to make significant progress toward advancing our clinical and commercial goals in the second qua ...


IntelGenx Closes Second Tranche of Convertible Debenture Offering

SAINT LAURENT, QUEBEC -- (Marketwired) -- 08/08/17 -- IntelGenx Technologies Corp. (TSX VENTURE: IGX)(OTCQX: IGXT) (the "Corporation" or "IntelGenx") is pleased to announce that it has closed a second tranche of its prospectus offering (the "Offering") of convertible unsecured subordinated debentures of the Corporation (the "Debentures"), pursuant to which it has raised additional gross proceeds of CDN$762,000.Together with the principal amount of CDN$6,838,000 of Debentures issued on July 12, 2017 (the "Initial Issuance Date"), the Corporati ...


BioElectronics Announces Update on Migraine Clinical Study Migraine Prevention Using ActiPatch (Neuromodulation Therapy)

FREDERICK, MD -- (Marketwired) -- 08/08/17 -- BioElectronics Corporation (OTC PINK: BIEL), is pleased to report on the progress of its Migraine prevention clinical study. The randomized, double-blinded, sham-controlled study involving 48 subjects is designed to investigate if ActiPatch therapy can be used to prevent the frequency and intensity of migraine attacks. Since receiving IRB-approval for the protocol in May 2017, 32 subjects (66%) have been successfully enrolled into the study.The principal investigator (PI) leading the study is Dr. Barry Eppley, M.D., D.M.D., a plastic surgeon at t ...


IntelGenx to Report Second Quarter 2017 Financial Results on August 10, 2017 - Conference Call to Follow

SAINT-LAURENT, QUEBEC -- (Marketwired) -- 08/03/17 -- IntelGenx Technologies Corp., (TSX VENTURE: IGX)(OTCQX: IGXT), today announced that it will release its second quarter 2017 financial results after market close on August 10, 2017.An accompanying conference call will be hosted by Dr. Horst G. Zerbe, President and Chief Executive Officer, and Mr. Andre Godin, Executive Vice-President and Chief Financial Officer, to discuss the results and provide a business update. Details of the conference call and webcast are below:Webcast Registration:Following the live call, a replay will be available o ...


Quad Cities Hand Surgeon Helps Develop Micro-Invasive Carpal Tunnel Treatment

DAVENPORT, IA -- (Marketwired) -- 08/02/17 -- Providing effective treatment for carpal tunnel syndrome (CTS) is of primary concern to Dr. Tyson Cobb, an orthopaedic . To better assist patients suffering from this common condition, he helped to develop a procedure called ultrasound-guided , which utilizes the innovative Sonex SX-One MicroKnife™. He says the advanced technique and instrument can reduce downtime, minimize pain, and improve results.Dr. Cobb explains that this new method of carpal tunnel release can be performed in-office or in a surgical center and requires only local anesthetic, ...


Lexaria Bioscience Corp. Engages NetworkNewsWire for Corporate Communications Solutions

NEW YORK, NY -- (Marketwired) -- 08/02/17 -- Lexaria Bioscience Corp. ("the Company") (OTCQB: LXRP) (CSE: LXX), an innovative company licensing proprietary technology for delivery of bioactive compounds including cannabinoids, announces that it has engaged the corporate communications expertise of ("NNW")."We are excited to be on the cutting-edge of bioscience, developing better ways to deliver health-enhancing cannabinoids to the body," says Lexaria Bioscience CEO and chairman of the board Chris Bunka. "As we continue to fulfil our mission of improving our ...


Vetted, the Rapidly Growing In-home Vet Care Platform, Raises $3.3 Million

LOS ANGELES, CA -- (Marketwired) -- 08/02/17 -- , the rapidly growing in-home vet care platform, today announced a $3.3 million dollar Seed round of funding led by Foundation Capital, with Amplify LA also participating in the round. Vetted provides pet owners with high quality, on-demand and affordable veterinary services and video consultations in the comfort of their own homes. Vetted will use the funds to expand its services to new regions, recruit additional highly trained veterinarians and to launch better solutions for pet owners and their pets.Currently serving areas of Los Angeles, wi ...


VPR Brands, LP welcomes the FDA''s recent announcement regarding electronic cigarette regulations

FORT LAUDERDALE, FL -- (Marketwired) -- 08/01/17 -- VPR Brands, LP (OTC PINK: VPRB), a market leader specializing in vaporizers and accessories for essential oils, cannabis concentrates, and extracts, as well as the maker of the KRAVE and VAPORIN brand electronic cigarettes containing nicotine, welcomes the FDA''s recent announcement delaying the regulatory timetable for electronic cigarettes until August 8th, 2022. Electronic cigarettes can help ween smokers off of traditional cigarettes and give smokers the nicotine they crave without many of the dangerous chemicals in cigarette s ...


Evolve BioSystems, Inc. announces Timothy B. Brown as new CEO, David Kyle named Executive Chairman and Chief Scientific Officer

DAVIS, CA -- (Marketwired) -- 08/01/17 -- The Board of Directors of Evolve BioSystems, Inc. has appointed Timothy B. Brown as CEO effective August 1, 2017. Mr. Brown will also join the Company''s Board of Directors effective that same date. Dr. David J. Kyle, the Company''s current CEO, will assume the new role of Executive Chairman of the Board of Directors of the Company and remain active as Evolve''s Chief Scientific Officer.Mr. Brown has served as Evolve BioSystems'' Chief Operating Officer since joining the company in May 2016. He is a veteran of t ...


Tauriga Sciences, Inc. and Ice + Jam LLC Prepare for Autumn 2017 Commercial Product Launch with Commencement of Laboratory Work to Reformulate Cupuacu Butter Lip Balm Product Texture

NEW YORK, NY -- (Marketwired) -- 07/25/17 -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in the building of life sciences businesses and technologies, today announced that, in cooperation with its licensor Ice + Jam LLC ("Ice + Jam"), it is working with New Jersey based Cosmetics R & D Laboratory, Ariel Laboratories ("Ariel Labs"), to reformulate its proprietary Cupuacu Lip Balm Product (Branded as: "HerMan"). In preparation for its anticipated Autumn 2017 commercial product launch, Tauriga has prioritized ...


Tauriga Sciences Inc. Confirms Trial Date of November 14, 2017 and that its Motion for Jury Trial has been Granted by Presiding Judge Peter G. Sheridan -- Federal District Court New Jersey (Courthouse Location: Trenton, New Jersey)

NEW YORK, NY -- (Marketwired) -- 07/25/17 -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in the building of life sciences businesses and technologies, today announced that its Motion for Jury Trial has been Granted by the presiding judge Peter G. Sheridan ("the Judge") in its ongoing litigation against its predecessor audit firm, Cowan Gunteski & Co. P.A. ("Cowan Gunteski"). Additionally, as part of this ruling, the Judge confirmed a Trial Date of November 14, 2017 at 10:00am EST -- Federal District Court New Jersey ...


IntelGenx Presents at BIT''s 7th Annual International Symposium of Drug Delivery Systems

SAINT LAURENT, QUEBEC -- (Marketwired) -- 07/12/17 -- IntelGenx Corp. (TSX VENTURE: IGX)(OTCQX: IGXT) (the "Company" or "IntelGenx") announced that Dr. Rodolphe Obeid, its Director of Research and Development, Process Development and Manufacturing Scale-Up, discussed the Company''s oral films based on its proprietary VersaFilm™ technology platform during a presentation today at BIT''s 7th Annual Symposium of Drug Delivery Systems being held in Prague, Czech Republic.Entitled "Oral Film Technology Evolution, Challenges and Therapeutic Benefits,&quo ...


Two Ogilvy CommonHealth Worldwide executives honored as ELITE Award winners by PM360

PARSIPPANY, NJ -- (Marketwired) -- 07/12/17 -- Ogilvy CommonHealth Worldwide (), the health behavior change specialists of Ogilvy & Mather () and a WPP Health & Wellness company (NASDAQ: WPPGY) (), today announced that Iyiola Obayomi, senior director, marketing analytics, and Angelo Campano, director, customer experience (EHR & CRM), were honored by leading health-marketing industry trade magazine PM360 at the third annual ELITE awards.The PM360 ELITE (Exceptional -- Leaders -- Innovators -- Transformers -- Entrepreneurs) Awards represent the most influential people in the healthc ...


IntelGenx Completes CDN$6.8 Million Convertible Debenture Offering

SAINT LAURENT, QUEBEC -- (Marketwired) -- 07/12/17 -- IntelGenx Technologies Corp. (TSX VENTURE: IGX)(OTCQX: IGXT) (the "Corporation" or "IntelGenx") is pleased to announce that it has closed its previously announced prospectus offering (the "Offering") of convertible unsecured subordinated debentures of the Corporation (the "Debentures") for gross aggregate proceeds of CDN$6,838,000.Pursuant to the Offering, the Corporation issued an aggregate principal amount of CDN$6,838,000 of Debentures at a price of CDN$1,000 per Debenture. The Debentures will ma ...


Nutrition 21 Velositol Gains GRAS Status

PURCHASE, NY -- (Marketwired) -- 07/10/17 -- Nutrition 21''s patented ingredient combining amylopectin and chromium, brand named Velositol, has attained GRAS (generally recognized as safe) status after an extensive and rigorous review of the scientific dossier and safety data conducted by Intertek Health Sciences, Inc. Velositol was determined to be GRAS at the recommended serving of 2 grams per day in protein drinks (including ready-to-drink and powder), meal replacement bars, energy and protein bars; with the consideration that these products can be taken up to three times a day.A ...


Nephros Provides Corporate Update and Second Quarter 2017 Revenue Guidance

RIVER EDGE, NJ -- (Marketwired) -- 07/10/17 -- Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), is providing a general update on the Company''s activities and guidance for the second quarter of 2016.New CMS Water Safety Requirements for Hospitals, Critical Access Hospitals and Long-term Care FacilitiesIn ...


BioElectronics to Present at 2017 UK Community Pharmacists'' Meeting

FREDERICK, MD -- (Marketwired) -- 06/30/17 -- BioElectronics Corporation (OTC PINK: BIEL) , is pleased to announce that Sree Koneru, Ph. D., VP of Product Development, will speak about the new science and technology behind chronic pain relief at the 2017 UK Pharmacy Forward Annual Conference.This meeting brings together independent and small-chain pharmacists for a one-day event, scheduled to be held at the London Olympia in London, England on July 2nd. Dr. Koneru''s presentation is designed to help pharmacists understand how they can use ActiPatch® Musculoskeletal Pain Therapy to h ...


IntelGenx Files Final Short Form Prospectus In Connection With Offering of Convertible Unsecured Debentures

SAINT LAURENT, QUEBEC -- (Marketwired) -- 06/29/17 -- IntelGenx Technologies Corp. (TSX VENTURE: IGX)(OTCQX: IGXT) (the "Corporation" or "IntelGenx") is pleased to announce that it has filed a final short form prospectus (the "Prospectus") in connection with an offering (the "Offering") of a minimum of Cdn$5,000,000 and a maximum of Cdn$10,000,000 aggregate principal amount of 8% convertible unsecured subordinated debentures due June 30, 2020 (the "Debentures"). The Corporation has also filed an amended registration statement on Form S-1 (the ...


Tauriga Sciences Inc. and Ice + Jam LLC Targeting Autumn 2017 Product Launch with Initial Inventory Base of 10,000-15,000 Units with Display Cases and Promotional Literature

NEW YORK, NY -- (Marketwired) -- 06/27/17 -- Tauriga Sciences Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in the building of life sciences businesses and technologies, announced that it is targeting the autumn of 2017 for its major product launch of its Cupuacu Butter lip balm product, called HERMAN™ in partnership with Cleveland, Ohio based cosmetics firm Ice + Jam LLC ("Ice + Jam"). The Company anticipates an initial inventory base of 10,000-15,000 units with completed display cases and promotional literature for the contemplated launch. Tauriga ...


Page 1 from 93:  1 2  3  4  5  .. » 93

All members: 7 999
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 86

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.